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ABSTRACT
A series of metal complexes of Cu(II), Zn(II) and Hg(II) having the general composition [M(L)2X2] [where L = thiourea;
M = Cu(II), Zn(II) or Hg(II) and X = Cl–, NO3
– or CH3COO
–] have been synthesized. All the metal complexes were characterized by
elemental chemical analysis, molar conductance, magnetic susceptibility measurements and IR spectroscopy. Cu(II) complexes
were additionally characterized by electronic and EPR spectral studies. The IR spectral data suggests the involvement of sulphur
atom in coordination to the central metal ion. On the basis of spectral studies square planar geometry has been assigned to Cu(II)
complexes except [Cu(L)2(CH3COO
–)2] which exhibits six coordinated tetragonal geometry. However, all Zn(II) and Hg(II)
complexes exhibited tetrahedral geometry. Furthermore, to achieve a better pharmacological profile, thiourea and its metal com-
plexes were screened for in vitro antimicrobial activity against the human pathogenic bacteria Staphylococcus aureus, Staphylococ-
cus epidermides, Escherichia coli and Pseudomonas aeruginosa and against the fungi Candida albicans and Aspergillus niger.
Thiourea and its metal complexes were also screened for in vivo anti-inflammatory activity. Thiourea did not exhibit antibacterial
activity but showed antifungal activity. However, it is important to note that the Cu(II), Zn(II) and Hg(II) complexes of thiourea
exhibited antibacterial and enhanced antifungal activity. Neither thiourea nor its metal complexes exhibited anti-inflammatory
activity.
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1. Introduction
Inorganic elements play crucial roles in biological and biomed-
ical processes, and it is evident that many organic compounds
used in medicine do not have a purely organic mode of action.
Some are activated or biotransformed by metal ions including
metalloenzymes. Others have a direct or indirect effect on metal
ion metabolism. The field of medicinal inorganic chemistry has
been stimulated by the success of cisplatin, the world’s best
selling anticancer drug.1 Copper, zinc and mercury metals have a
well-established importance in the field of medicine. Copper
plays a vital role in the development and performance of the
human nervous and cardiovascular system as well as the skin,
bone, immune and reproductive system including gene tran-
scription.2 Copper histidine complex is given as a supplement
for Menkes disease treatment.3 Zinc plays an important role in
various biological systems and is a vital component, an essential
cofactor, critical for numerous cellular processes and may be a
regulatory ion in the metabolism of cells.4 Zinc citrate is a supple-
ment, ZnO is widely used as a skin ointment and Zn(II) bicyclam
complexes possess antiviral activity.3 Thimerosal is an ethyl-
mercury containing pharmaceutical compound developed in
1927. It continues to remain as an effective preservative in
vaccines and other injectable biological products, including
Rho(D)–immune globulin preparation.5
Ligands containing a thioamide structure have considerable
coordination potential. The flexibility based on the tautomerism,
thiol (–N=C(–SH)) ! thione (–NH–C(=S)), can afford various
coordination modes (Fig. 1). Thiourea is potentially capable of
forming coordinate bonds through both sulphur and nitrogen.
Structural studies using spectroscopic techniques (IR and
NMR) of thiourea complexes of silver(I), [Ag((Tu)2Cl, Ag(Tu)2SCN
and Ag(Tu)3ClO4 where Tu = thiourea] have shown that
thiourea can act both as a bridging and terminal ligand.6 A
number of studies on metal coordination compounds of
thiourea derivatives with inorganic salts have been reported.
They have been found to possess a wide variety of biological
activities like antifungal, antibacterial and hypolipidemic activ-
ity.7–9 However, studies dealing with the complexes of thiourea
with metal salts and their biological activities are scarce. A variety
of compounds containing thiourea can be obtained depending
on the method of preparation and also on the anion used. The
control of the geometry around a metal ion is important for
controlling the properties of a compound. In this paper we
report the synthesis, spectroscopic, in vitro antimicrobial and
in vivo anti-inflammatory activity of the Cu(II), Zn(II) and Hg(II)
complexes of thiourea.
2. Materials and Methods
2.1. Instrumentation
The C, H, and N were analysed on Carlo-Erba 1106 elemental
analyser. Molar conductance was measured with the ELICO
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Figure 1 The tautomeric structures of thiourea.
(CM82T) conductivity bridge. The magnetic susceptibilities
were measured at room temperature on a Gouy balance using
CuSO4.5H2O as callibrant. Diamagnetic corrections were made
by using Pascal’s constants. IR spectra (KBr) were recorded on
FTIR spectrum BX-II spectrophotometer. The electronic spectra
were recorded in DMSO on Shimadzu UV mini-1240
spectrophotometer. The molecular weights of the complexes
were determined cryoscopically in benzene. The EPR spectra of
the complexes were recorded at room temperature on a E4–EPR
spectrometer using DPPH as the g-marker.
2.2. Materials
All the chemicals used were of analytical grade and were pro-
cured from Sigma Aldrich and Fluka. Metal salts were purchased
from E. Merck and used as received.
2.3. General Method of Synthesis of Complexes
An ethanolic solution (20 mL) of thiourea (0.02 mol) and an
ethanolic solution (20 mL) of the corresponding metal salt
(0.01 mol), heated to a temperature of 50 °C, were mixed together
with constant stirring. The mixture was refluxed for 3–4 h at
50–55 °C. On cooling, coloured complexes precipitated. These
were filtered off, washed with 50 % ethanol, and dried under
vaccum over fused CaCl2.
2.4. In vitro Antimicrobial Activity
In vitro antimicrobial screening was performed by the agar disc
diffusion method.10,11 All the test organisms were obtained from
Microbial Type Culture Collection and Gene Bank (MTCC),
Institute of Microbial Technology, Chandigarh, India. Nutrient
agar growth media was prepared according to the instructions
of MTCC. 25 mL nutrient agar media was poured into each
petriplate of 90 mm diameter. The inoculum was spread on the
top of solidified media. Sterile discs of Whatmann no. 1 filter
paper, having a diameter of 6 mm, impregnated with the test
compounds, were placed at four equidistant places on the inocu-
lated petriplates. The zone of inhibition was calculated in milli-
meters. The antibacterial activity of the thiourea and its metal
complexes were tested against Gram-positive (Staphylococcus
aureus and Staphylococcus epidermides) and Gram-negative (Esche-
richia coli and Pseudomonas aeruginosa) pathogenic bacteria at a
concentration of 100 µg disc–1. Nutrient agar media was prepared
by using peptone, beef extract, yeast extract, NaCl, agar-agar and
distilled water.1 2 Bacterial cultures were adjusted to
0.5 McFarland turbidity standard and inoculated onto the
nutrient agar plates.13 The discs were carefully transferred onto
the seeded agar plates. Filter paper disc treated with DMSO
served as control and Amikacin (30 µg disc–1) was used as a
standard drug. All determinations were made in duplicate for
each of the compounds. An average of two independent read-
ings for each compound was recorded. The petriplates were
incubated at 37 °C for 24 h before the zone of inhibition was
calculated.
The antifungal activity of the thiourea and its metal complexes
were tested against two pathogenic fungi, Candida albicans and
Aspergillus niger at a concentration of 200 µg disc–1 for each.
Nystatin (200 µg disc–1) was used as standard fungicide and
DMSO served as a means of control. For Candida albicans nutrient
agar media was prepared using yeast extract, peptone dextrose,
agar-agar and distilled water.12 Inoculum suspension in normal
saline was prepared from fresh, mature (3–5 days old) cultures
grown on nutrient agar slants. Using spectrophotometry at
530 nm, turbidity was measured and adjusted to match a
0.5 McFarland density standard resulting in an inoculum
containing 1 ! 106 to 5 ! 106 fungal cells mL–1.14 This suspension
was used to directly inoculate agar plates.
For Aspergillus niger, nutrient agar media was prepared using
czapek concentrate (NaNO3, KCl, MgSO4.7H2O, FeSO4.7H2O
and distilled water), K2HPO4, yeast extract, sucrose, agar-agar
and distilled water.12 Seven-day-old colonies were covered with
approximately 1 mL of sterile 0.85 % saline and the suspensions
were made by gently probing the colonies. The resulting mixture
of conidia and hyphal fragments was withdrawn and trans-
ferred into sterile tube. After heavy particles were allowed to
settle for 3–5 min, the upper homogenous suspensions were col-
lected. The densities of the conidial suspensions were read and
adjusted to an optical density (OD) that ranged from 0.09 to 0.11
(80 to 82 % transmittance) at 530 nm.15 The sterile discs impreg-
nated with the test compounds were placed on the already
seeded plates at 30 °C for 48 h. A clearing zone around the disc
indicated the inhibition activity of the test compounds on the
pathogenic fungi.
2.5. In vivo Anti-inflammatory Activity
Anti-inflammatory activity of thiourea and its complexes was
determined by carrageenan induced paw oedema model. The
animal experimental protocols were approved by the Institutional
Animal Ethics Committee (Sanction No: ITS–01/IAEC/2009).
Thirty-six Wistar albino rats, 24 females and 12 males, weighing
150–200 g were used. They were kept in polypropylene cages at
25 ± 2 °C under 12 h light and dark cycles. The rats had free ac-
cess to the rat feed pellets and drinking water. The animals were
randomly divided into one control, one reference and four test
groups comprising six rats each.
Oedema was induced by injecting 0.1 mL of 1 % w/v carra-
geenan in 0.9 % NaCl into the subplantar region of the rat’s hind
paw. The four test groups were treated orally with 10 mg kg–1 of
test compounds namely thiourea (L), [Cu(L)2Cl2], [Zn(L)2Cl2] and
[Hg(L)2Cl2], 30 min before carrageenan injection. The control
group received 10 mL kg–1 saline and the reference group
received 10 mg kg–1 indomethacin orally. Measurement of paw
size was done 3 h following carrageenan injection. The inhibi-
tory activity was calculated according to the following equa-
tion.16
Percentage inhibition =
(Ct Co) (Ct Co) treate! ! ! d
(Ct Co) control!
" 100 ,
where Ct is the paw circumference at time t, Co is the paw
circumference before carrageenan injection, Ct – Co is oedema,
(Ct – Co) control is oedema or paw size after carrageenan injec-
tion to control rats at time t.
All the results were expressed as mean ± SEM and the data
were statistically analysed by the Student t-test, where P < 0.001
was considered statistically significant.
3. Results and Discussion
Thiourea behaves as a monodentate ligand coordinating
through the sulphur. The analytical data, magnetic susceptibility
and spectral analysis agree well with the proposed composition
of Cu(II), Zn(II) and Hg(II) complexes of thiourea as shown in
Table 1. The molar conductance of the complexes in DMF lies in
the range of 12–16 "–1 cm2 mol–1 indicating their nonelectrolyte
behaviour. Thus, the complexes may be formulated as [M(L)2X2],
(where M = Cu(II), Zn(II) or Hg(II); L = thiourea; X = Cl–, NO3–
or CH3COO–) (Fig. 2).
3.1. IR Spectra
The assignments of the significant IR spectral bands of
thiourea and its metal complexes are presented in Table 2. In
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principle, thiourea exhibit thiol-thione tautomerism since it
contains a thioamide –NH–C=S functional group. The #(S–H)
band at 2500–2600 cm–1 is absent in the IR spectrum of thiourea,
but the #(NH) band, at 3367 cm–1, is present, indicating that, in
the solid state, thiourea remains as the thione tautomer.17
Thiourea exhibits two pairs of asymmetric and symmetric
#(NH2) stretching vibrations in the high frequency region of
3400–3000 cm–1. The bands due to #as(NH2) at 3392 and 3273 cm–1
and the bands due to #s(NH2) at 3175 and 3092 cm–1 are not
shifted to lower frequencies upon formation of the metal
thiourea complex, indicating that nitrogen to metal bonds are
not present and that the bonding must be between sulphur and
metal atoms.18 The characteristic absorption frequencies of
thiourea at 1474 and 1083 cm–1 are due to asymmetric and
symmetric #(N–C–N) stretching vibrational modes. These peaks
are shifted towards higher frequencies in metal complexes. The
increase in the frequency can be attributed to the greater double
bond character of the carbon to nitrogen bond on complex for-
mation.19 The characteristic bands of thiourea at 1415 and
730 cm–1 are due to asymmetric and symmetric #(C=S) stretching
vibrations. Upon complex formation, the band of thiourea at
1415 cm–1 shows an asymmetric splitting, while the band at
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Table 1 Analytical data of the complexes.
Compounds Mol. Wt found Yield /% Colour Mp /°C Analysis found (calcd.)
(calcd.) /gm
C H N M
[Cu(L)2Cl2] 285 68 green >350 8.35 2.76 19.60 22.18
(286) (8.39) (2.79) (19.56) (22.20)
[Cu(L)2(NO3)2] 340 64 green 163 7.06 2.38 24.70 18.73
(340) (7.07) (2.35) (24.73) (18.70)
[Cu(L)2(CH3COO)2] 335 65 green >350 21.61 4.17 16.75 19.08
(334) (21.59) (4.19) (16.78) (19.05)
[Zn(L)2Cl2] 290 60 white 210 8.36 2.79 19.40 22.66
(288) (8.33) (2.77) (19.44) (22.69)
[Zn(L)2(NO3)2] 340 60 white 180 7.00 2.36 24.63 19.13
(341) (7.03) (2.34) (24.60) (19.14)
[Zn(L)2(CH3COO)2] 335 61 white 240 21.46 4.20 16.70 19.46
(336) (21.47) (4.17) (16.69) (19.48)
[Hg(L)2Cl2] 422 68 white 210 5.66 1.91 13.24 47.40
(423) (5.67) (1.89) (13.23) (47.39)
[Hg(L)2(NO3)2] 475 62 grey >350 5.02 1.66 17.60 42.16
(477) (5.03) (1.67) (17.62) (42.14)
[Hg(L)2(CH3COO)2] 470 64 white >350 15.33 2.96 11.90 42.62
(471) (15.30) (2.97) (11.89) (42.61)
Table 2 Important IR spectral bands (cm–1) of thiourea and its complexes.
Compounds #as(N–C–N) #a(N–C–N) #as(C=S) #s(C=S) S–M–S
CH4N2S (L) 1474 1083 1415 730 –
[Cu(L)2Cl2] 1509 1106 1414 696 474
1390
[Cu(L)2(NO3)2] 1522 1093 1415 636 478
1320
[Cu(L)2(CH3COO)2] 1504 1107 1434 723 477
1408
[Zn(L)2Cl2] 1483 1093 1439 709 476
1389
[Zn(L)2(NO3)2] 1496 1105 1446 715 477
1407
[Zn(L)2(CH3COO)2] 1504 1107 1434 725 477
1408
[Hg(L)2Cl2] 1503 1110 1438 714 479
1406
[Hg(L)2(NO3)2] 1522 1109 1420 618 473
1395
[Hg(L)2(CH3COO)2] 1522 1112 1381 697 473
1325
703 cm–1 shifts towards lower frequency. The coordination of
thiourea ligand to copper, zinc and mercury atoms is realized
through the sulphur atom in the complex by observed lowering
of #(C=S) frequencies attributed to the reduced double bond
character of the #(C=S) band.20 Metal sulphur bonds present in
the compound is also evident from the peaks at 479–473 cm–1 in
the complexes due to antisymmetric S–M–S stretching as well as
C–N deformation.21 In each complex, two thiourea ligands coor-
dinate to the central metal ion through two S atoms. Thus, it is
concluded that the ligand acts as a unidentate chelating agent
In the IR spectra of chloro complexes, bands corresponding to
#(M–Cl) are observed at 345–320 cm–1 indicating the pres ence of
an M–Cl bond.22 The presence of bands at 1420–1415, 1320–1280,
and 1051–1018 cm–1, in the IR spectra of the nitrato complexes
suggests that both nitrate groups are coordinated to the central
metal ion in a unidentate manner.23 IR spectra of the Cu(II) ace-
tate complex shows two absorption bands at 1646 and 1504 cm–1
which are assigned to #as(CO2–) and #s(CO2–) of CH3COO–ion. The
stretching frequency difference [#(#as – #s) = 142 cm–1] is smaller
than that of CH3COONa (ca. 195 cm–1), indicating that the coordi-
nation of CH3COO–ion is bidentate.24 IR spectra of Zn(II) and
Hg(II) acetate complexes show medium intensity bands at
1620–1618 and 1325–1322 cm–1. These bands are mainly due to
monodentate CH3COO–.23
3.2. Magnetic Susceptibility
As shown in Table 3, magnetic moment observed for the Cu(II)
complexes lies within the range of 1.90–1.94 BM, corresponding
to one unpaired electron.
3.3. Electronic Spectra
The electronic spectra (Table 3) of Cu(L)2Cl2 and Cu(L)2(NO3)2
complexes show absorption bands at 19010 and 19380 cm–1,
respectively, due to 2B1g $ 2Eg transition in a square planar geom-
etry25. The bands at 24038 and 24271 cm–1 respectively may be
attributed to M $ L charge transfer.26 The electronic spectra of
Cu(L)2(CH3COO)2 shows an absorption band at 10438 cm–1. This
band correspond to the transition 2B1g $ 2A1g (dx2–y2 $ dz2) in a
tetragonal geometry, while the band at 29586 cm–1 may be
attributed to M $ L charge transfer.27
3.4. EPR Spectra
Room temperature EPR spectra of Cu(II) complexes (Figs 3–5)
were recorded as polycrystalline samples at room temperature.
The g|| and g% have been calculated and observed in the range
2.2498–2.2576 and 2.0641–2.0773, respectively (Table 3). These
data support the idea that dx2–y2 may be the ground state (g|| >
g% > 2.0023) (16). G = (g|| – 2)/(g% , which measures the
exchange interaction between the metal centres in a poly-
crystalline solid, has been calculated. According to Hathaway28,
if G > 4, the exchange interaction is negligible, but G < 4 indi-
cates considerable exchange interaction in solid complexes.
All the Cu(II) complexes reported in this paper give the ‘G’
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Figure 3 EPR spectra of [Cu(L)2Cl2].
Figure 2 Suggested structure of the complexes. (a) [M(CH4N2S)2X2],
where M = Cu(II), Zn(II) or Hg(II) and X = Cl– or NO3–; [Zn(CH4N2S)2
(CH3COO)2] or [Hg(CH4N2S)2(CH3COO)2]. (b) [Cu(CH4N2S)2
(CH3COO)2].
values < 4, indicating the exchange interaction in the solid
complexes.
3.5. In vitro Antimicrobial Activity
The antimicrobial screening data given in Table 4 show that
thiourea did not inhibit growth of bacteria but exhibited
antifungal activities. It is important to know that it’s metal chelates
exhibited antibacterial activities against Gram-positive (Staphy-
lococcus aureus and Staphylococcus epidermides) and Gram-
negative (Escherichia coli and Pseudomonas aeruginosa) pathogenic
bacteria and showed increased antifungal activities against
Candida albicans and Aspergillus niger. [Cu(L)2Cl2], [Zn(L)2Cl2] and
[Hg(L)2Cl2] are found to be the most active amongst the series of
Cu(II), Zn(II) and Hg(II) complexes synthesized.
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Figure 4 EPR spectra of [Cu(L)2(NO3)2].
Table 3 Magnetic moment, electronic and EPR spectral data of the copper complexes.
Complexes µeff BM &max /cm–1 g|| g% G
[Cu(L)2Cl2] 1.85 19010, 24038 2.0773 2.257 3.3324
[Cu(L)2(NO3)2] 1.83 19380, 24271 2.0641 2.249 3.8970
[Cu(L)2(CH3COO)2] 1.89 10438, 29586 2.0706 2.2498 3.5382
Figure 5 EPR spectra of [Cu(L)2(CH3COO)2].
Formation of complexes with transition metal ions has been
proposed as a step in the antimicrobial activity of thiourea. The
increased activity of metal chelates can be explained on the basis
of chelation theory.29 It is known that chelation tends to make the
ligand act as a more powerful and potent bactericidal agent. It is
observed that, in a complex, the positive charge of the metal is
partially shared with the donor atoms present in the ligand, and
there may be ' electron delocalization over the whole chelate. This
increases the lipophilic character of the metal chelate and favors
its permeation through the lipoid layer of the bacterial mem-
branes. There are other factors which also increase the activity,
namely solubility, conductivity, and bond length between the
metal and the ligand.
3.6. In vivo Anti-inflammatory Activity
The anti-inflammatory screening data given in Table 6 show
that thiourea and its metal complexes do not exhibit anti-
inflammatory activity
4. Conclusion
The proposed study revealed tetrahedral geometry for Zn(II)
and Hg(II) complexes whereas square planar geometry for
Cu(II) complexes except [Cu(L)2(CH3COO)2] which possesses six
coordinated tetragonal geometry. Thiourea acts as monodentate
chelating agent coordinating through the sulphur atom. It is
important to note that thiourea did not inhibit growth of bacteria
but exhibited antifungal activity. However Cu(II), Zn(II) and
Hg(II) complexes of thiourea exhibited antibacterial and enhanced
antifungal activity. Neither thiourea nor its metal complexes
exhibited in vivo anti-inflammatory activity. Cu(II) complexes
were found to be biologically more active than Zn(II) and Hg(II)
complexes. Moreover, the presence of chloride ions in the metal
complexes improves their antimicrobial activity due to forma-
tion of hypochlorous acid.30 Free chloride upon oxidation results
into chlorine that reacts with water according to the following
proposed reaction:
Cl2 + H2O $ HCl + HClO.
The hypochlorous acid formed, further decomposes forming
hydrochloric acid.
2HClO $ 2HCl + O2 .
The O2 released in the above reaction is a strong oxidizing
agent and it destroys microbes by oxidizing cellular components.
Antimicrobial action of chlorine compounds is also due to
the combination of chlorine with proteins and enzymes of mem-
branes.
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